Loading...
The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study
BACKGROUND: Dopamine D2-like receptors are attenuated in aldosterone producing adenoma, lead to overproduction of aldosterone in affected patients, and thus reported to serve as a potential treatment target for primary aldosteronism. The D2 dopamine receptor agonist bromocriptine has been used clini...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652803/ https://ncbi.nlm.nih.gov/pubmed/29100412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20670 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|